Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia

Infection Control and Hospital Epidemiology

Volumn 30, Issue 8, 2009, Pages 759-763

  Shorr, Andrew F ^a   Zilberberg, Marya D ^b   Kollef, Marin ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b EviMed Research Group LLC   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILVER;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; HOSPITAL COST; INCIDENCE; INFECTION RISK; INTERMETHOD COMPARISON; MATERIAL COATING; MONTE CARLO METHOD; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA;

COST-BENEFIT ANALYSIS; EQUIPMENT CONTAMINATION; HOSPITAL COSTS; HUMANS; INCIDENCE; INFECTION CONTROL; INTUBATION, INTRATRACHEAL; MONTE CARLO METHOD; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; SILVER COMPOUNDS;

EID: 67651085427     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/599005     Document Type: Article

References (31)

1. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control 2007; 35:290-301.
2. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115-2121.
3. Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004; 25:1090-1096.
4. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184-2193.
5. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31:1312-1317.
6. Anderson DJ, Kirkland KB, Kaye KS, et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol 2007; 28:767-773.
7. Petering HG. Pharmacology and toxicology of heavy metals: silver. Pharmacol Ther 1976; 1:127-130.
8. Ahearn DG, Grace DT, Jennings MJ, et al. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol 2000; 41:120-125.
9. Gabriel MM, Sawant AD, Simmons RB, Ahearn DG. Effects of silver on adherence of bacteria to urinary catheters: in vitro studies. Curr Microbiol 1995; 30:17-22.
10. Berra L, De Marchi L, Yu ZX, Laquerriere P, Baccarelli A, Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology 2004; 100:1446-1456.
11. Chandra J, Patel JD, Li J, et al. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 2005; 71:8795-8801.
12. Cunliffe D, Smart CA, Alexander C, Vulfson EN. Bacterial adhesion at synthetic surfaces. Appl Environ Microbiol 1999; 65:4995-5002.
13. Patel JD, Ebert M, Ward R, Anderson JM. S. epidermidis biofilm formation: effects of biomaterial surface chemistry and serum proteins. J Biomed Mater Res A 2007; 80:742-751.
14. Tebbs SE, Elliott TS. Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Eur J Clin Microbiol Infect Dis 1994; 13:111-117.
15. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300:805-814.
16. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276:1253-1258.
17. Bureau of Labor Statistics of the US Department of Labor. Consumer Price Index. Available at: http://www.bls.gov/data. Accessed August 10, 2007.
18. Klompas M, Platt R. Ventilator-associated pneumonia-the wrong quality measure for benchmarking. Ann Intern Med 2007; 147:803-805.
19. Shorr AF, O'Malley PG. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest 2001; 119:228-235.
20. Lai KK, Baker SP, Fontecchio SA. Impact of a program of intensive surveillance and interventions targeting ventilated patients in the reduction of ventilator-associated pneumonia and its cost-effectiveness. Infect Control Hosp Epidemiol 2003; 24:859-863.
21. van Nieuwenhoven CA, Buskens E, Bergmans DC, van Tiel FH, Ramsay G, Bonten MJ. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units. Crit Care Med 2004; 32:126-130.
22. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006; 130:251-260.
23. Babcock HM, Zack JE, Garrison T, et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004; 125:2224-2231.
24. Zack JE, Garrison T, Trovillion E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002; 30:2407-2412.
25. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nursestaffing levels and the quality of care in hospitals. N Engl J Med 2002; 346: 1715-1722.
26. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340:627-634.
27. Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence-based guidelines for preventing ventilator- associated pneumonia? a survey based on the opinions of an international panel of intensivists. Chest 2002; 122:656-661.
28. Ricart M, Lorente C, Diaz E, Kollef MH, Rello J. Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia. Crit Care Med 2003; 31:2693-2696.
29. Esteban A, Anzueto A, Alia I, et al. How is mechanical ventilation employed in the intensive care unit? an international utilization review. Am J Respir Crit Care Med 2000; 161:1450-1458.
30. Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002; 287:345-355.
31. Freeman BD, Borecki IB, Coopersmith CM, Buchman TG. Relationship between tracheostomy timing and duration of mechanical ventilation in critically ill patients. Crit Care Med 2005; 33:2513-2520.